{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T06:38:52Z","timestamp":1768891132357,"version":"3.49.0"},"reference-count":28,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Amyloid"],"published-print":{"date-parts":[[2018,7,3]]},"DOI":"10.1080\/13506129.2018.1519507","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T23:49:01Z","timestamp":1541202541000},"page":"197-202","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":57,"title":["Diflunisal tolerability in transthyretin cardiac amyloidosis: a single center\u2019s experience"],"prefix":"10.1080","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0532-8991","authenticated-orcid":false,"given":"Asad","family":"Ikram","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8254-433X","authenticated-orcid":false,"given":"Joseph P.","family":"Donnelly","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett W.","family":"Sperry","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christy","family":"Samaras","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5605-7020","authenticated-orcid":false,"given":"Jason","family":"Valent","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazen","family":"Hanna","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,11,2]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.84.s3.02"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2002.223"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0696"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.04.030"},{"key":"CIT0005","unstructured":"Sekijima Y, Yoshida K, Tokuda T, et\u00a0al. Familial transthyretin amyloidosis. 2001 Nov 5 [Updated 2012 Jan 26]. In: Adam MP, Ardinger HH, Pagon RA, et\u00a0al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132017. Available from: https:\/\/www-ncbi-nlm-nih-gov.ccmain.ohionet.org\/books\/NBK1194\/."},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-013-0182-4"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-015-0653-1"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.06.011"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-309914"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1126\/science.1062245"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1126\/science.1079589"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1080\/13506120600960882"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700059"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.283815"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2008.525"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7133.2012.00303.x"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021612"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1097\/01.EDE.0000034633.74133.C3"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4857"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.14.2093"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199209103271101"},{"key":"CIT0022","unstructured":"Dolobid (diflunisal) [package insert]. Merck & Co., Inc., Whitehouse Station, NJ; 1988."},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2014.997872"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002877"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.01.042"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx589"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004769"},{"key":"CIT0028","unstructured":"Pfizer Announces Positive Topline Results From Phase 3 ATTR-ACT Study Of Tafamidis In Patients With Transthyretin Cardiomyopathy [news release]. New York, NY: Pfizer Inc Media Relations; 2018 Mar 29 [cited 2018 Jul 9]. http:\/\/press.pfizer.com\/press-release\/pfizer-announces-positive-topline-results-phase-3-attr-act-study-tafamidis-patients-tr."}],"container-title":["Amyloid"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13506129.2018.1519507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:20:30Z","timestamp":1599438030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13506129.2018.1519507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7,3]]}},"alternative-id":["10.1080\/13506129.2018.1519507"],"URL":"https:\/\/doi.org\/10.1080\/13506129.2018.1519507","relation":{},"ISSN":["1350-6129","1744-2818"],"issn-type":[{"value":"1350-6129","type":"print"},{"value":"1744-2818","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iamy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iamy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-06-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}